Pharmacologic characterization in vitro and in vivo of iodine 123-labeled derivatives of the β-adrenoceptor antagonist CGP12177, designed for the imaging of cardiac β-receptors

Journal of Nuclear Cardiology

Volumn 3, Issue 3, 1996, Pages 242-252

  Dubois, Eric A ^a   Somsen, G Aernout ^b   Van Den Bos, Jan C ^b   Janssen, Anton G M ^b   Boer, Gerard J ^b   Batink, Harry D ^b   Van Royen, Eric A ^b   Pfaffendorf, Martin ^b   Van Zwieten, Pieter A ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NONE

Author keywords

CGP12177; Heart failure; adrenoceptors

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; IODINE 123; ISOPRENALINE; NADOLOL; PROPRANOLOL; RADIOLIGAND;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; DRUG UPTAKE; HEART LEFT VENTRICLE; HEART MUSCLE; HEART RIGHT ATRIUM; IMAGING; INTRAVENOUS DRUG ADMINISTRATION; IODINATION; ISOTOPE LABELING; LUNG PARENCHYMA; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; RECEPTOR AFFINITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0029990579     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-3581(96)90038-0     Document Type: Article

References (40)

1. Lands AM, Arnold A, McAuliff JP, Luduena FP, Brown TG. Differentiation of receptor systems activated by sympathomimetic amines. Nature 1967;214:597-8.
2. Baumann G, Riess G, Erhardt WD, et al. Impaired beta-adrenergic stimulation in the uninvolved ventricle post-acute myocardial infarction: reversible defect due to excessive circulation catecnolamine-induced decline in number and affinity of beta-adrenoceptors. Am Heart J 1981;101:569-81.
3. Francis GS, Cohn JN. Heart failure: mechanisms of cardiac and vascular dysfunction and the rationale for pharmacologic intervention. FASEB J 1990;4:3068-75.
4. Maisel AS, Motulsky HJ, Insel PA. Externalization of beta-adrenergic receptors promoted by myocardial ischemia. Science 1985;230:183-6.
5. Baker SP. Effect of thyroid status on beta-adrenoceptors and muscarinic receptors in the rat lung. J Auton Pharmacol 1981;1: 269-77.
6. Latifpour J, McNeill JM. Cardiac autonomic receptors: effect of long-term experimental diabetes. J Pharmacol Exp Ther 1984;230: 242-9.
7. Kashiwagi A, Nishio Y, Saeki Y, Kida Y, Kodama M, Shigeta Y. Plasma membrane-specific deficiency in cardiac beta-adrenergic receptor in streptozocin-diabetic rats. Am J Physiol 1989;257: E127-32.
8. Brodde OE, Daul A, Michel MC, Zerkowski HR. Importance of beta 2-adrenergic receptors in heart failure. Z Kardiol 1992; 81(suppl):71-8.
9. Brodde OE, Zerkowski HR, Doetsch N, Motomura S, Khamssi M, Michel MC. Myocardial beta-adrenoceptor changes in heart failure: concomitant reduction in beta 1- and beta 2-adrenoceptor function related to the degree of heart failure in patients with mitral valve disease. J Am Coll Cardiol 1989;14:323-31.
10. Brodde OE. Chronic beta-1 blocker treatment and cardiac beta-2 adrenoceptor function [letter]. Am Heart J 1992;123:1727-8.
11. Brodde OE, Zerkowski HR, Borst HG, Maier W, Michel MC. Drug-and disease-induced changes of human cardiac beta-1 and beta-2 adrenoceptors. Eur Heart J 1989;10(suppl):38-44.
12. Bristow MR, Ginsburg R, Umans V, et al. Beta-1 and beta-2 adrenergic receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta-1 receptor down-regulation in heart failure. Circ Res 1986;59:297-309.
13. Bristow MR, Kantrowitz NE, Ginsburg R, Fowler MB. Beta-adrenergic function in heart muscle disease and heart failure. J Mol Cell Cardiol 1985;17(suppl):41-52.
14. Fowler MB, Laser JA, Hopkins GL, Minobe W, Bristow MR. Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. Circulation 1986;74:1290-302.
15. Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311:819-23.
16. Kosugi M, Shimizu K, Ohtani A, Migita T. Palladium catalyzed reaction of hexabutylditin with aryl bromides: preparation of negatively substituted aryltributyltin. Chem Lett 1981:829-30.
17. Delforge J, Syrota A, Lancon JP, et al. Cardiac beta-adrenergic receptor density measured in vivo using PET, CGP 12177, and a new graphical method. J Nucl Med 1991;32:739-48.
18. Merlet P, Delforge J, Syrota A, et al. Positron emission tomography with 11C CGP-12177 to assess beta- adrenergic receptor concentration in idiopathic dilated cardiomyopathy. Circulation 1993;87:1169-78.
19. Sibley DR, Strasser RH, Benovic JL, Daniel K, Lefkowitz RJ. Phosphorylation/dephosphorylation of the beta-adrenergic receptor regulates its functional coupling to adenylate cyclase and subcellular distribution. Proc Natl Acad Sci USA 1986;83:9408-12.
20. Collins S, Bouvier M, Lohse MJ, Benovic JL, Caron MG, Lefkowitz RJ. Mechanisms involved in adrenergic receptor desensitization. Biochem Soc Trans 1990;18:541-4.
21. Sisson JC, Wieland DM, Koeppe RA, et al. Scintigraphic portrayal of beta receptors in the heart. J Nucl Med 1991;32:1399-407.
22. Hillmann-Elies A, Hillmann G, Schiedt U. 2-Iodoestrone and 2-iodoestradiol. Z Naturforsch [B] 1953;8:436-40.
23. Janssen DE, Wilson CV. 4-Iodoveratrole. Organic Synth Coll 1963;4:457-9.
24. Weinstock LM, Mulvey DM, Tull R. Synthesis of the beta-adrenergic blocking agent timolol from optically active precursors. J Organic Chem 1976;41:3121-4.
25. Baldwin JJ, Hirschmann R, Lumma WC Jr, Ponticello GS, Sweet CS, Scriabine A. An approach to peripheral vasodilator-beta-blocking agents. J Med Chem 1977;20:1024.
26. Hammadi A, Crouzel C. Stereoselective synthesis of the (R)- and (S)-1-(2-amino-3-ntrophenoxy)-3-(tert-butylamino)-2-propanol from the enatiomeric glycidyl tosylates. Tetrahedron Asymmetry 1990;1:579-82.
27. Hammadi A, Crouzel C. Asymmetric synthesis of (2S)- and (2R)-4-(3-t-butylamino-2-hydrxypropoxy)-benzimidazol-2-[11C]-one((S) and (R)-[11C]CGP12177) from optically active precursors. J Lab Comp Radiopharm 1991;29:681-90.
28. Witsenboer AJ, de Goeij JJM, Reiffers S. Production of iodine-123 via proton irradiation of 99.8% enriched xenon-124. J Lab Comp Radiopharm 1986;23:1284-5.
29. 125Iodo] cyanopindolol, a new ligand for beta-adrenoceptors: identification and quantitation of subclasses of beta-adrenoceptors in guinea pig. Naunyn Schmiedebergs Arch Pharmacol 1981;317:277-85.
30. Waagstein F. Beta blockers in heart failure. Cardiology 1993; 82(suppl):13-8.
31. Fowler MB. Controlled trials with beta blockers in heart failure: metoprolol as the prototype. Am J Cardiol 1993;71:45C-53C.
32. Brodde OE. Pathophysiology of the beta-adrenoceptor system in chronic heart failure: consequences for treatment with agonists, partial agonists or antagonists? Eur Heart J 1991;12(suppl):54-62.
33. Persson H, Erhardt L. Beta receptor antagonists in the treatment of heart failure. Cardiovasc Drugs Ther 1991;5:589-604.
34. Eichhorn EJ, Sobotka P. Novel approaches to congestive heart failure: use of beta-adrenergic blockade. Coronary Artery Dis 1994;5:101-6.
35. Brady F, Luthra SK, Tochon-Dangy HJ, et al. Asymmetric synthesis of a precursor for the automated radiosynthesis of S-(3'-t-butylamino-2′-hydroxypropoxy)-benzimidazol-2-[11C]-one (S-[11C]-CGP12177) as a preferred radioligand for beta-adrenergic receptors. Int J Radiat Appl Instrum [A] 1991;42:621-8.
36. Bristow MR. Changes in myocardial and vascular receptors in heart failure. J Am Coll Cardiol 1993;22:61A-71A.
37. Maisel AS, Phillips C, Michel MC, Ziegler MG, Carter SM. Regulation of cardiac beta-adrenergic receptors by captopril: implications for congestive heart failure. Circulation 1989;80:669-75.
38. Delehanty JM, Himura Y, Elam H, Hood WB Jr, Liang CS. Beta-adrenoceptor downregulation in pacing-induced heart failure is associated with increased interstitial NE content. Am J Physiol 1994;266:H930-5.
39. Brodde OE. Beta-adrenoceptors in cardiac disease. Pharmcol Ther 1993;60:405-30.
40. Steinfath M, Lavicky J, Schmitz W, Scholz H, Doring V, Kalmar P. Changes in cardiac beta-adrenoceptors in human heart diseases: relationship to the degree of heart failure and further evidence for etiology-related regulation of beta 1 and beta 2 subtypes. J Cardiothorac Vasc Anesth 1993;7:668-73.